Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions

International Journal of Infectious Diseases

Volumn 37, Issue , 2015, Pages 135-142

  Wang, Hye young ^a   Park, Sunyoung ^b   Lee, Dongsup ^b,c   Kim, Sunghyun ^d   Kim, Geehyuk ^b   Park, Kwang Hwa ^e   Lee, Hyeyoung ^b  

^a Wonju Eco Environmental Technology Center   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Hyejeon University   (South Korea)

^d Catholic University of Pusan   (South Korea)

^e Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Cervical cancer; E6 E7 mRNA; HPV; Molecular diagnosis; Prevalence; RT qPCR

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN E7;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN TISSUE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MOLECULAR DIAGNOSIS; PAPILLOMAVIRUS INFECTION; PREVALENCE; SOUTH KOREA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR KIT; WART VIRUS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REPUBLIC OF KOREA; RNA, MESSENGER; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84938070380     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.06.018     Document Type: Article

References (29)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Syrjänen K. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors. Eur J Gynaecol Oncol 2008, 29:205-221.
4. Ergünay K., Misirlioğlu M., Pinar F., Tuncer Z.S., Tuncer S., Ustaçelebi S. Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus. Mikrobiyol Bul 2007, 41:219-226.
5. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005, 366:991-998.
6. Gillison M.L., Broutian T., Pickard R.K., Tong Z.Y., Xiao W., Kahle L., et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012, 307:693-703.
7. Castle P.E., Stoler M.H., Wright T.C., Sharma A., Wright T.L., Behrens C.M. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 2011, 12:880-890.
8. Mantovani F., Banks L. The interaction between p53 and papillomaviruses. Semin Cancer Biol 1999, 9:387-395.
9. Howie H.L., Katzenellenbogen R.A., Galloway D.A. The human papillomavirus E6 proteins. Virology 2009, 384:324-334.
10. McLaughlin-Drubin M.E., Münger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384:335-344.
11. Klingelhutz A.J., Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 2012, 424:77-98.
12. Castellsagué X., Schneider A., Kaufmann A.M., Bosch F.X. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 2009, 115:S15-S23.
13. Bae J.H., Lee S.J., Kim C.J., Hur S.Y., Park Y.G., Lee W.C., et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008, 18:788-794.
14. Kim S., Lee D., Park S., Kim T.U., Jeon B.Y., Park K.H., et al. REBA HPV-ID® for efficient genotyping of human papillomavirus in clinical samples from Korean patients. J Med Virol 2012, 84:1248-1253.
15. Ronco G., Giorgi-Rossi P., Carozzi F. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008, 100:492-501. New Technologies for Cervical Cancer Screening Working Group.
16. Lie A.K., Risberg B., Borge B., Sandstad B., Delabie J., Rimala R., et al. DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 2005, 97:908-915.
17. Castle P.E., Dockter J., Giachetti C., Garcia F.A., McCormick M.K., Mitchell A.L., et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res 2007, 13:2599-2605.
18. Juric D., Mahovlić V., Rajhvajn S., Ovanin-Rakić A., Skopljanac-Macina L., Barisić A., et al. Liquid-based cytology-new possibilities in the diagnosis of cervical lesions. Coll Antropol 2010, 34:19-24.
19. Coquillard G., Palao B., Patterson B.K. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011, 120:89-93.
20. Persson M., Brismar Wendel S., Ljungblad L., Johansson B., Weiderpass E., Andersson S. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia. Oncol Rep 2012, 28:346-352.
21. Varnai A.D., Bollmann M., Bankfalvi A., Speich N., Schmitt C., Griefingholt H., et al. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications. Oncol Rep 2008, 19:457-465.
22. Luu H.N., Adler-Storthz K., Dillon L.M., Follen M., Scheurer M.E. Comparing the performance of Hybrid Capture II and polymerase chain reaction (PCR) for the identification of cervical dysplasia in the screening and diagnostic settings. Clin Med Insights Oncol 2013, 7:247-255.
23. De Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., Zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
24. Agarossi A., Ferrazzi E., Parazzini F., Perno C.F., Ghisoni L. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 2009, 81:529-535.
25. Kjaer S.K., Breugelmans G., Munk C., Junge J., Watson M., Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123:1864-1870.
26. Pannier-Stockman C., Segard C., Bennamar S., Gondry J., Boulanger J.C., Sevestre H., et al. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. J Clin Virol 2008, 42:353-360.
27. Datta S.D., Koutsky L.A., Ratelle S., Unger E.R., Shlay J., McClain T., et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med 2008, 148:493-500.
28. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121:621-632.
29. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.